Craig Mull

About Craig Mull

Craig Mull is the Chairman and Interim Chief Executive Officer of Cipher Pharmaceuticals, a publicly traded company. He holds 10.29 million shares, representing a ten percent ownership in the company. He has discussed the company's strategy to acquire and commercialize prescription medicines.

Craig Mull at a glance

• Company: Cipher Pharmaceuticals

More founder profiles (44)

• Zheng Xu — Missfresh
• Shay Segev — DAZN
• Ali Diab — Collective Health
• Fabien Pinckaers — Odoo
• Remon Vos — CTP
• Meg Whitman — Quibi
• Anthony Hayes — Dominari Holdings
• Troy Swope — Footprint
• Jon Brause — World Food Programme
• Tom Hogan — Perficient
• Steven Hudson — ECN Capital
• Yariv Milchan — New Regency Productions
• Jeffrey Jump — MedAlliance
• Charlie Morrison — Jersey Mike's Subs
• Yichen Shen — Lightelligence
• Rahul Singhvi — Resilience
• John Simon — Simon Property Group
• Tom Hale — Oura
• Marc Ganzi — DigitalBridge
• Vijay Sharma — One97
• Bruce Flatt — EduCo
• Oren Frank — Talkspace
• Alison Brittain — Whitbread
• Arkady Volozh — Yandex
• Bhavish Aggarwal — Ola
• Lin Xiong — Ziroom
• Ritesh Agarwal — OYO Hotels & Homes (Singapore)
• Chris Bayne — The Access Group
• Philippe Corrot — Mirakl
• Fred Creighton — Dufry
• Gary Jordan — euNetworks Group
• Zhibin Feng — Sinochem Energy
• Hugh Rienhoff — Imago BioSciences
• Linda Hasenfratz — Linamar
• Anthony Thomas — Mynt
• Yang Lei — Hello TransTech
• David Marek — Myovant Sciences
• Maegha Rambal — Perdaman
• Brendon Merkley — SunStrong Management
• Mark Crossley — Indivior
• Mohamed Fardan — Masdar Capital
• Josh Goldstein — Plus Power
• Priit Lepasepp — Sunly
• Nicholas Clark — Divvy

Browse related founder lists (1)

• Founders who raised $50M+

Full founder directory · Investor directory · Company funding database · Fundraising library